Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
3 studies found for:    20004787 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Enrolling by invitation Evaluation and Long-Term Follow-Up of Patients With Allergic and Inflammatory Disorders
Conditions: Allergy;   Asthma;   Allergic Rhinitis;   Mastocytosis;   Atopic Dermatitis;   Food Allergy
Intervention:
2 Completed Omalizumab to Treat Eosinophilic Gastroenteritis
Condition: Gastroenteritis
Intervention: Drug: Omalizumab
3 Recruiting Study of Mast Cell Precursors
Conditions: Normal Physiology;   Systemic Mastocytosis
Intervention:

Indicates status has not been verified in more than two years